Dried matrix spots and clinical elemental analysis. Current status, difficulties, and opportunities by Resano, M. et al.
1Dried matrix spots and clinical elemental analysis. Current 
status, difficulties, and opportunities. 
M. Resanoa*, M. A. Belarraa, E. García-Ruiza, M. Aramendíaa,b, L. Relloc
a Department of Analytical Chemistry, Aragón Institute of Engineering Research 
(I3A), University of Zaragoza, Pedro Cerbuna 12, 50009, Zaragoza, Spain. E-
mail: mresano@unizar.es 
b Centro Universitario de la Defensa, Carretera de Huesca s/n, 50090, Zaragoza, 
Spain
c Department of Clinical Biochemistry, Hospital Universitario “Miguel Servet”, 
Paseo Isabel La Católica 1–3, 50009, Zaragoza, Spain
Abstract
This article examines the increasing importance of dried matrix spot (DMS) 
specimens (such as dried blood spots, dried urine spots, etc.) in biomedical 
research, the challenges associated with their analysis when quantitative 
elemental information is aimed at, as well as the benefits deriving from the further 
usage of these types of samples. The article briefly reviews the historical 
evolution of this sampling approach in elemental clinical analysis, stressing 
prospective areas of applications (e.g., newborns or prosthesis control), the 
methodologies most recently developed to produce DMS of known volume, as 
well as novel strategies proposed to analyze them, often related to direct solid 
sampling techniques or fast lixiviation methods. Finally, the article discusses the 
type of information that could be obtained after isotopic analysis of DMS when 
targeting non-traditional stable isotopes (e.g., Cu, Fe or Zn), which can 
significantly help in the early diagnosis of some medical conditions (e.g. Wilson's 
disease). 
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31. Introduction
In 1963, R. Guthrie and A. Susi published a seminal work describing the collection 
of capillary blood from the heel of newborns. Such method included the 
deposition of a few blood droplets on a filter paper (FP), a drying step, and, finally, 
the determination of phenylalanine for the screening of phenylketonuria [1].
This was actually not the first paper dealing with the microanalysis of blood 
collected on FP. Already in 1913, Bang described the determination of blood 
sugar levels by titration with a diluted iodine solution [2]. However, it can be 
argued that it was the work referred above by Guthrie and Susi [1] the one that 
laid the conceptual basis of an approach that has facilitated the diagnosis and 
early treatment of multiple congenital and hereditary abnormalities through 
newborn screening programs. Since then, analysis of the now called DBS (Dried 
Blood Spots) has improved or saved many lives in both developed and 
developing countries [3].
The number of analytes investigated in DBS samples has been steadily 
increasing, with applications in metabolic-endocrine diagnosis, therapeutic drug 
monitoring, as well as toxicological, serological and molecular biology studies [4-
7]. Moreover, in recent years (see Figure 1a), there has been an exponential 
increase in the number of publications on this topic, which seemed to peak in 
2014. The slow decrease in papers observed in the last couple of years does not 
necessarily mean that the interest in the field has decreased. Instead, it could 
mean that the field is reaching a state of maturity, as the pharmaceutical industry 
is using more and more this type of sample [8]. Also, some of the research is 
being transferred to the use of other biological fluids, such as urine (see Figure 
41b), giving rise to the so-called dried urine spots (DUS), and, to a much lesser 
extent, to other fluids such as cerebrospinal fluid [9,10], amniotic fluid [11] or 
saliva [12]. Biological samples deposited onto and dried on a FP receive the 
generic name of DMS (Dried Matrix Spots).
The majority of this research has been focused on the monitoring of (bio) organic 
species via liquid chromatography-mass spectrometry (LC-MS). Several recent 
reviews covered these works [3,13-16] in detail. The current review will instead 
focus on the role that this field may also play in clinical elemental analysis. 
Obviously, some of the aspects discussed can be considered as general, 
regardless of the nature of the analyte, which will be noted. However, one of the 
key differences of clinical elemental analysis is that typically quantitative 
information is aimed at, as opposed to many other situations in clinical diagnosis 
where only qualitative or screening information is needed. This still represents an 
analytical challenge for DMS analysis. 
2. Advantages of DMS for the analysis of biological fluids
From a purely analytical point of view, by producing DMS, liquid samples that are 
relatively simple to analyze after digestion or just dilution, are transformed into 
much more complex solid materials, which are typically not homogeneous. 
Therefore, from such point of view, this transformation is not so advantageous. 
Moreover, deposition of other liquid materials on FP is also possible, and has 
been also explored in the literature [17,18], but such applications are rarely finally 
deployed in routine labs. 
5Therefore, what are the benefits of DMS to make this type of sample worthy of 
analytical research? There are a significant number of them, which will be 
discussed below.
2.1. Ease of sample collection
This advantage is particularly important in the case of blood. Development of the 
DBS methodology has been related to the expansion of neonatal screening 
programs in hospitals, because the method of collecting capillary blood on FP is 
very attractive for mass screening of children for the following reasons [19]: i) a 
minimal amount of blood is required; ii) pricking the heel (newborns) or finger 
(young children) with a lancet is easier and less traumatic than the conventional 
collection of venous blood; and iii) DBS collection can be performed by relatively 
untrained personnel, even by the parents or relatives at home (see Figure 2). 
DMS are becoming also popular for this reason in a pharmacological context 
(e.g., experimentation with new drugs or treatments). The traditional method of 
collection of blood from rodents is terminal, thus requiring a new animal for each 
measurement. Alternatively, DBS methodology enables serial sampling from a 
single animal, such that pharmaceutical companies can meet the "3R's doctrine" 
(reduction, refinement, and replacement) as regards animal experimentation [14].
Concerning other biological fluids, use of urine or saliva permits the development 
of truly non-invasive methods, although the amount of sample is typically not a 
problem for urine. In the case of other samples, such as cerebrospinal or amniotic 
fluids, the advantages are not so obvious, because sampling must be carried out 
by specialized medical staff following the hospitalization of the patient. Still, these 
venues are explored because of the increasing popularity of DMS. 
2.2. Ease of transportation and storage
6This is another key aspect for clinical labs. Requirements for transportation and 
storage of biological specimens collected on FP are much less stringent than 
those that have to be followed for the liquid samples. For example, many urinary 
metabolites show little stability. Thus, urine must be frozen (at -20 °C or -80 °C) 
until analysis, complicating the logistics of clinical laboratories, which often have 
to deal with hundreds of samples on a daily basis. 
In contrast, several studies indicate that the conservation of the sample dried on 
a FP slows down the degradation processes that analytes may undergo [20], and 
therefore DMS are much more stable than the original wet samples. If the 
analysis is to be carried out one month after collection or before, it is generally 
possible to preserve DMS at room temperature; for longer periods, it is 
recommended to keep them refrigerated under controlled humidity [5].
2.3. Improvement of welfare conditions 
For the reasons discussed before, DMS methodology enables the home 
collection of biological fluids and their submission to the lab by ordinary mail. This 
aspect can certainly improve the quality of life of people who must periodically 
undergo tests, such as chronic patients requiring frequent controls, or those with 
reduced mobility or, even, bedridden, and/or those living in isolated areas.
In addition, this strategy can lead to health care and business savings, 
decreasing the hours of staff dedicated to the collection of the samples, as well 
as to administrative aspects related with the frequent attention of patients in 
health centers.
2.4. Increased participation in epidemiological or population-based 
prevention programs
7Both epidemiological and population-based preventive programs make use of the 
measurement of biomarkers and, in such studies, the collaboration of the 
population is essential. This collaboration involves certain discomforts to 
participating subjects: sample collection can be annoying (e.g., blood collection) 
and it often requires a visit to a health center for collection or delivery of the 
sample. When the study is epidemiological, in which the participants do not see 
a clear benefit for their participation (in contrast to a program of prevention or of 
early diagnosis of a disease), these inconveniences may outweigh their 
collaborative spirit.
In these situations, the development of protocols for the collection of these 
biospecimens at home and their easy shipment should lead to greater 
participation [21]. As stated by McDade et al.: “…the burden is on the researcher 
to bring methods to people in the community instead of relying on select 
individuals willing to come to the clinic or lab” [5]. Thus, use of DMS (especially 
DBS and DUS) can help in these cases.
2.5. Conducting retrospective research with samples available from 
newborn screening programs
DBS samples are collected virtually from all newborns in many countries. Thus, 
this sampling strategy provides a way of preserving whole blood samples that 
may be used in retrospective research in clinical, epidemiological and 
toxicological areas, as novel techniques and methodologies are developed [22]. 
The creation of biobanks that can provide further information without bothering 
again the patient is thus another significant advantage. 
8Overall, to conclude this section it can be stated that the main advantages of 
using DMS are not analytical, quite the contrary. It is certainly easier for atomic 
spectrometry techniques, such as graphite furnace atomic absorption 
spectrometry (GF-AAS) or inductively coupled plasma mass spectrometry (ICP-
MS), to deal with blood or urine samples in liquid form (diluted or digested) than 
with DMS. But this sample offers so many benefits for the patients and for the 
clinical community that is becoming widely used. It is thus the duty of the 
analytical community to try to meet the challenges brought by this methodology 
and provide analytical data as reliable as necessary. 
3. Filter materials for preparing DMS
There is a variety of commercially available FPs that can be used for clinical 
purposes. These materials differ, among other characteristics, in weight, 
thickness, speed of absorption and in the presence (or absence) of some 
chemical compounds, added for particular applications. The key requirements of 
a FP to produce a DMS and achieve reproducible analytical results are that its 
capacity of absorption and dissemination of the sample are uniform, and that 
these properties are maintained between different units of both the same and 
different lots.
In the particular case of DBS samples, there is much more information on the 
performance of FPs, resulting in regulations/recommendations. The Clinical and 
Laboratory Standard Institute has set the requirements so that FPs can be used 
in the preparation of DBS specimens in neonatal screening programs. Currently, 
only two brands of FPs are approved as class II medical devices: Whatman 903 
and Perkin Elmer 226, which are 100% made of cotton linters and contain no 
9additives [23]. Several studies have demonstrated that these papers are virtually 
identical in terms of its analytical capabilities [4].
With the level of quality accomplished, Mei et al. pointed out that: "The filter paper 
blood collection device has achieved the same level of precision and 
reproducibility that analytical scientists and clinicians have come to expect from 
standard methods of collecting blood, such as vacuum tubes and capillary 
pipettes. Like these devices, filter paper has associated with it some level of 
imprecision that can be characterized to standardize the device and to minimize 
the variation in measurements due to the filter paper matrix" [24].
However, despite these positive comments, the situation may still be subject to 
further improvements. One important aspect is that the FP material used should 
retain a constant amount of blood per area unit (of course, within a reasonable 
interval), so that for analyte quantification it may not be necessary to know the 
exact volume of blood that is deposited in the DBS for its formation. This is, 
however, not so simple to achieve, because the amount of blood (or of fluid, in 
general) deposited per area unit may depend to some extent on the 
physicochemical characteristics of every sample. For instance, it has been 
reported for DBS that the amount of hematocrit may have an influence on this 
parameter [25].
That is why this is an area of current research and there are different 
manufacturers investigating the use of alternative materials (frequently polymeric 
compounds), while also trying to simplify the procedure of sample collection. 
One of such cases has given rise to the so-called volumetric absorptive 
microsampling (VAMS) method. In this method, in order to produce a DBS, a 
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puncture with a safety lancet is typically performed on the finger of the individual 
and a small and known volume (approx. 10.5 μL for blood) is retained on the 
absorptive tip of the device (see Figure 3a), which is made of a polymer 
specifically designed for this purpose [26]. Moreover, it has been shown that the 
collected sample volume is practically independent of the hematocrit level [26], 
although this value may still affect the extraction efficiency, as discussed in detail 
in the first review published on the use and performance of VAMS [27]. 
An alternative and also very recent approach is based on the so-called 
microfluidic-based volumetric sampling. This device incorporates several 
channels of a constant volume that aspirate blood (5 or 10 μL) from the finger, 
and further deposit it onto a clinical FP (see Figure 3b). Any type of FP that fits 
the device can be used. This approach has also been reported to enable 
quantitative blood analysis, regardless of the hematocrit level [28,29].
Other alternatives and modifications have been proposed in the literature, such 
as using precut filters to control diffusion, or adding some compounds to the filter 
to be used as internal standards and/or to help in retaining some species. Such 
cases will be commented in the next sections, focusing on approaches reported 
for elemental analysis only. 
4. The analytical process for dried matrix spots samples
Figure 2 illustrates the typical procedure for analysis of DBS. After the sample is 
collected according to the recommendations [23], which can be done after 
puncturing the heel (newborns) or the finger, it is dried and can be sent to the 
laboratory for analysis. 
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As discussed before, the space occupied by a droplet is not always constant. 
This aspect is problematic for quantification unless: i) the whole DMS is 
completely analyzed; and ii) the volume of the droplet is known (e.g., deposited 
with a pipette) [30]. 
Very often these requisites are not fulfilled. The whole DBS is often too large for 
analysis and a smaller disc (diameters of 1.5, 3.2, 4.7 and 6.0 mm are standard 
values) is punched out of it and analyzed. Such procedure ensures obtaining 
sufficient sample for various measurements and also easier automation, as many 
of these small pieces can be pretreated (e.g., analyte extraction) simultaneously 
before their analysis. On the other hand, deposition with a pipette or a calibrated 
capillary is often considered not appropriate for home collection. In this context, 
the use of alternative procedures, such as those discussed in the previous 
section (Figure 3), can be beneficial. 
In any case, these piece(s) of the DBS are typically submitted to an extraction 
procedure, and the extract is finally analyzed. When elemental information is 
aimed at, this is most often carried out via GF-AAS or ICP-MS. In the latter case, 
an internal standard is usually added to the extract before analysis. Examples of 
these procedures will be discussed in the next section. 
Alternatively, the use of a solid sampling technique can make this process more 
straightforward, although the procedure for calibration needs to be carefully 
designed, and it often requires the usage of matrix-matched standards. Pros and 
cons of such approach will be discussed in section 5.3. 
Finally, for biological fluids other than blood the procedure has not been yet 
standardized. However, a similar approach to that depicted in Figure 2 is usually 
12
followed, but using of a pipette for sample deposition is typical, unless the patient 
suffers from urine incontinency, in which case a FP can be placed inside his/her 
diapers. In the case of urine, using the standard 24-hour collection procedure 
would be preferable. Otherwise, creatinine should also be determined for 
normalization of the results. The particular problems arising from DUS elemental 
analysis will be discussed in the next section as well. 
5. DMS for elemental analysis 
5.1. The origin: Pb blood levels and the Delves Cup
The element most determined in DMS by a large margin is Pb. This was the first 
element to be investigated and still is widely monitored in DBS: of the 48 articles 
listed in Table 1, 36 are devoted to Pb, or to Pb and other elements. 
There is an obvious reason for this: Pb is an important neurotoxic and its effects 
may be particularly grave in the case of children, who can benefit significantly 
from the use of DBS, as discussed before. The topic was so relevant that early 
in the 70s a device called the Delves Cup was commercialized, enabling fast and 
sensitive determination of Pb in DBS by Flame (F)-AAS. Such device used micro 
crucibles made from nickel foil where the samples were deposited and partially 
oxidized with H2O2. Later, they were volatilised by an air-acetylene flame into a 
nickel absorption tube situated in the flame [31]. 
The first article devoted to this topic was not dealing with DMS, but with analysis 
of 10 μL of blood [31]. However, direct analysis of DBS using the Delves Cup was 
proposed only one year later by Cernik and Sayers, with the idea of enabling easy 
control of workers in Pb factories [32]. These authors, nevertheless, pointed out 
in the conclusions the potential of this approach in paediatric practice as well. 
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From that moment, many other papers were published aiming at improving this 
methodology, for instance, including a pre-ashing step to minimize the formation 
of smoke [33], which could cause interferences [34]. 
Many of these articles discuss aspects of the methodology that can have an 
impact in the final results, regardless of the analytical technique chosen, such as 
the comparison between capillary (as obtained by finger or heel prick) and 
venous (as obtained by phlebotomy) blood levels. In the majority of cases, it was 
accepted that comparable results could be obtained for both sampling methods. 
Another frequent issue is the potential contamination arising from two aspects: i) 
the content of Pb in the FP used; and, ii) contamination from the skin of the patient 
or from the atmosphere, when sampling is not performed in a clinical lab. The 
first case is not very relevant, in our experience, when Pb is the target, although 
blank FPs must always be monitored. The situation for other elements will be 
discussed later. For the second case, appropriate finger cleaning seems 
required, as well as some minimal training for proper blood deposition: the 
continuous application of blood is preferred over multiple discrete applications of 
blood drops of small volumes, which lead to non-circular geometries [35]. In any 
case, deposition of blood onto FPs is standardized nowadays [23]. 
Ever a critical aspect, the distribution of blood on the FP has been investigated 
in this context as well. It was already noticed in 1978 that, for a fixed sample 
volume, blood samples with lower haemoglobin levels spread over a larger area 
for a fixed volume [36]. This aspect affects the potential for achieving accurate 
results, at least for samples with extreme hematocrit values (most articles on DBS 
report/discuss on hematocrit values rather than on haemoglobin levels like ref. 
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[36], but both values are related) and also complicate method validation, because 
reconstituted reference materials also show a different consistency and tend to 
spread over a larger surface than real blood samples [37,38]. In any case, if the 
portion punched out is sufficiently large, it could be representative for Pb levels 
as long as the most outer circle (which is small but enriched in Pb) is not sampled 
[39,40]. 
5.2. GF-AAS and ICP-MS: responding to new elemental challenges
The popularity of F-AAS related methods was substituted by those based on GF- 
AAS and, later, by those deploying ICP-MS. This has led to the development of 
methods that are sensitive enough not only to monitor Pb, but many other 
elements as well. 
In most cases, an extraction step is required for these techniques. It can be seen 
that obtaining quantitative recovery from these samples is not an easy task as 
the procedures proposed evolved getting more complicated and using 3 or 4 
reagents [41-43]. ICP-MS adds simultaneous multi-element potential [44], but 
sometimes that represents further challenges to extract some analytes properly. 
For instance, Hg is another clinically relevant element owing to its well-
established toxicity, and up to 8 manuscripts have reported its determination in 
DBS. However, its accurate determination presents particular challenges, such 
as the typical high volatility of its compounds (even more if reduced to Hg (0)) 
and the tendency of some of its compounds to adhere to nonpolar surfaces (such 
as tubing). These factors often lead to poor recoveries as well as to memory 
effects [45], which require proper sample preparation and introduction strategies. 
For instance, Funk et al. [46] proposed the addition of Au in the extraction solution 
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to amalgamate Hg, thus enhancing recovery, as one of the improvements over 
the method previously proposed by Langer et al. [44] for multi-element analysis 
of DBS, method which finally did not include Hg among the elements determined 
due to poor reproducibility/stability. A more recent article by Nelson et al. [47] 
compares the results obtained for paired cord blood and DBS samples. This type 
of study is of obvious interest because the use of DBS could be ideal to establish 
fetal exposure to mercury, which is an important issue as even minimal amounts 
of Hg can have a severe effect on a still not fully developed brain and nervous 
system. However, the results reported show underestimated values for DBS and 
higher limits of detection (LOD): 0.7 μg L-1 for analysis of DBS vs 0.3 μg L-1 for 
analysis of cord blood. These results simply reflect that analysis of DBS is more 
challenging than traditional analysis of blood, and even more so if a difficult 
element needs to be determined at levels below μg L-1. However, use of 
alternative digestion/extraction strategies or of solid sampling techniques, as will 
be discussed in the next section, could alleviate these issues. 
It is very well known that Hg toxicity depends on the physicochemical form in 
which this element is present. In this regard, the first paper on Hg speciation 
based on analysis of DBS has been published very recently by Basu et al. [48]. 
This pioneering work uses gas chromatography coupled to cold vapour atomic 
fluorescence spectroscopy (GC-CVAFS) to separate Hg species and to quantify 
Methylmercury (MeHg) levels, after sample digestion, offering a 0.3 μg L-1 LOD. 
Still, the article states that without sample volume information it is impossible to 
calculate an accurate concentration. This problem has been already discussed 
in section 3 and nowadays there are solutions available (see Figure 3), that 
could be tested for MeHg determination. It can also be highlighted that, for the 
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particular problem of Hg, CVAFS is a relatively simple but powerful technique, 
offering very low limits of detection and the possibility to analyze the samples 
directly. 
In any case, the possibilities offered by ICP-MS make it feasible to investigate 
many other elements that have become of clinical interest, besides the traditional 
toxic elements, which are of obvious relevance and not only for humans, but also 
for other animal species. Certainly, the use of DBS is particularly interesting for 
small animals, as the amount of blood required is very limited. This feature has 
been explored to create a database collecting information on the exposure of wild 
birds to environmental toxicants (As, Cd, Pb, Hg, together with several organic 
pollutants), based on DBS analysis [49], beginning with an examination of 
Eurasian Griffon Vultures in Israel [50].
The importance of controlling elements related with the presence of prosthesis 
can be highlighted. Nowadays, large hip and knee implants are made with 
complex alloys also including ceramic parts, and typically containing elements 
such as Cr, Co, Mo, Ti or V. Monitoring these elements has become of increasing 
interest, not necessarily because of their toxicity, but because the appearance of 
an abnormally high level might indicate prostheses malfunctioning, perhaps 
requiring a surgical replacement. However, there is still need to develop 
methodologies that can reliably determine these elements (and some that are 
particularly relevant, such as Ti) at the low levels at which they are present in 
controls (below ppb level) and patients [51]. 
The capability of the recently introduced ICP tandem mass spectrometry (ICP-
MS/MS) has demonstrated to be of particular relevance for this type of application 
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[52,53]. One of the main problems for the accurate determination of light (m/z 
below 80) elements is the occurrence of spectral overlap. ICP-MS/MS enables: 
i) the separation of most potential interferences in the first quadrupole; ii) a 
selective reaction of the ions of the target element with gases (e.g., CH3F, NH3 
or O2) in a cell, such that a new polyatomic species is formed; iii) the selective 
transmission of such polyatomic species through the second quadrupole. This 
constitutes the so-called mass-shift approach [54]. Thus, an element that suffers 
of so many potential interferences from elements that are present at high levels 
in biological fluids such as Ti (see Table 2) can be monitored and quantified 
practically interference-free in the form of Ti(NH3)6+ [55]. 
This technique has been successfully used to determine Ti, V, Co, Sr, and Zr in 
blood after deposition on a VAMS device (see section 3 for description), followed 
by a simple extraction step [56]. Al, Cr and Ni were monitored as well, but 
contamination issues affected their determination. 
An alternative for still achieving sufficiently low limits of detection without using 
ICP-MS/MS or other more expensive ICP-MS instruments (e.g., high-resolution 
sector field devices) is to limit the dilution. For instance, the use of a high 
temperature total sample consumption system (a micronebulizer connected to a 
low inner volume single pass spray chamber) enhances transport efficiency to 
almost 100%, enabling the introduction of very small sample volumes (e.g., 2.5 
μL). Thus, instead of diluting the blood deposited in the VAMS device (10.5 μL) 
in 1 mL to obtain enough sample for measuring at a typical aspiration rate using 
conventional introduction systems (0.5-1.0 mL min-1) [56], with this device it is 
feasible to extract the target elements in only 100 μL and still be able to perform 
as many replicates as needed [57]. 
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Regardless of the type of mass spectrometer or sampling introduction device 
used, an aspect that has to be further investigated is the contamination of the 
material used to produce the DMS, which probably has not been originally 
designed with trace and ultratrace elemental analysis in mind. As discussed 
before, the FP should not contain high amounts of Pb, but when other elements 
are being investigated, blanks may be a problem: "Adequate control of filter paper 
element contributions remains the primary obstacle to fully quantitative element 
measurement in newborn blood using NBSs (neonatal blood spots) [44]". 
Furthermore, blanks for different lots may vary [42]. When polymeric materials 
instead of FP are deployed, this problem also arises [56,57]. One solution could 
be the use of a precleaning step, until blanks for the target elements are 
sufficiently low [58,59], but always using conditions mild enough to prevent any 
alteration of the capacity of the materials to absorb biological fluids.
Another interesting element for DMS-based applications is iodine. Control of 
iodine levels are key to indicate thyroid dysfunctions. It is particularly important to 
control this parameter in pregnant women, to avoid that these dysfunctions can 
affect those children gestated in extreme conditions of iodine content.
Iodine is mostly excreted trough urine, so the iodine level in urine provides an 
reliable indicator of the iodine intake. In this context, after the first work of Zava 
et al. [60], in which an analytical methodology for I (and creatinine) determination 
in DUS was proposed, several works have used a similar procedure to investigate 
iodine urinary levels in pregnant women and/or children in particular areas of 
African countries (Burkina Faso, South Africa and Niger) [61-63], proving the 
suitability of using DMS for epidemiological studies, as already discussed in 
section 2.
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It can be pointed out that, while the spectrophotometric method used in these 
articles may be fit-for-purpose, there are techniques available nowadays (e.g. 
ICP-MS) that can provide more selectivity and a higher detection power for iodine, 
when required. 
5.3. Direct analysis of DMS 
One alternative approach that can mitigate to some extent contamination issues, 
not those created by contamination of the FP but those related with sample 
treatment, is the use of solid sampling techniques. Besides this aspect, recovery 
problems can also be avoided. Finally, the results can also be obtained faster. 
This latter aspect, however, depends a bit on the analytical procedure used, since 
automated systems that enable the simultaneous lixiviation of up to 96 discs 
(making use of the standard 96 well plates) are available, thus also improving 
sample throughput. 
In any case, since a DMS is a liquid that is finally transformed into a solid sample, 
and considering the availability of several analytical techniques capable of the 
direct analysis of these solid samples, it is not surprising to see that such 
techniques have been evaluated for DMS analysis. 
In fact, as discussed before, using the Delves Cup it was possible to determine 
Pb in a disc punched out from a DBS, with minimal sample treatment [32]. Other 
techniques may, however, provide more sensitivity and selectivity nowadays. In 
2007, both solid sampling (SS)-GF-AAS [40] and laser ablation (LA)-ICP-MS [37] 
were evaluated for Pb determination in DBS with very different results. In the case 
of SS-GF-AAS satisfactory quantitative results were obtained, using matrix-
matched standards for calibration. These standards were prepared from Pb-free 
20
blood samples spiked with known amounts of Pb, which were deposited onto the 
FP and dried, in the same way as the samples [40]. 
In the case of LA-ICP-MS, quantitative information could not be achieved and the 
differences between DBS prepared with real blood samples or reconstituted 
reference materials were noted [37]. 
The potential of SS-GF-AAS has been further enhanced during the last decade 
with the arrival of high-resolution continuum source graphite furnace atomic 
absorption spectrometry (HR CS GF-AAS) that, among other features, improves 
the resolution (down to approximately 1 pm) and the capabilities to detect and to 
correct for spectral interferences. Use of this instrumentation permitted to further 
improve Pb determination in DBS [64], avoiding any overlap from phosphates 
and enhancing the calibration range without the need for carrying out any 
additional measurements: signals that were outside the upper linear range could 
be reprocessed using side instead of central pixels, thus monitoring the wings of 
the atomic lines instead of the center. In such a way, it was possible to achieve a 
limit of detection of 1 μg L-1 and still determine Pb in DBS samples containing 
hundreds of μg L-1. The method proved its robustness after analysis of more than 
500 samples, and it was demonstrated that it could also be easily adapted to a 
screening method, able to provide a binary response in a simple way [65], as 
shown in Table 3. Discussing the statistical parameters usually calculated to 
evaluate the performance of a screening method is beyond the scope of the 
current work, although definitions are provided in the caption of Table 3. 
HR CS GF-AAS thus offers very interesting characteristics for monoelemental 
analysis of DMS. In fact, HR CS GF-AAS provides some possibilities for 
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simultaneous multi-element analysis, although restricted to elements with atomic 
transitions that are sufficiently close (a few hundreds of picometers), because 
that is the spectral region simultaneously covered by the detector. This aspect 
was explored to determine Mo and Ti in DUS [51]. 
Focusing on DUS, one critical aspect when trying to analyze urine instead of 
blood is that urine spreads much more over the surface of the FP, thus leading 
to a more inhomogeneous distribution of the analytes (chromatographic effect) 
and to lower sensitivity. To prevent these issues, use of a precut FP on top of a 
hydrophobic surface, making it possible to deposit a larger amount of urine and 
letting it dry, was earlier proposed by Aramendía et al. [66] (see Figure 4a). This 
procedure improves the amount of urine deposited per area unit by a factor of 10, 
approximately. The main steps of the protocol finally used for Mo and Ti 
determination in DUS are shown in Figure 4b. A volumetric deposition (500 μL 
of urine) on a precut FP and the use of matrix-matched standards (prepared with 
real urine samples spiked with known amounts of the analytes) enabled reliable 
quantitative results to be obtained, with LODs (1.5 μg L−1 for Mo and 6.5 μg L− 1 
for Ti), possibly low enough to detect prostheses malfunctioning, but not 
sufficiently low to determine Ti in controls and patients with a well-performing 
implant [51]. 
To achieve more detection power, much higher multi-element potential and even 
isotopic information, LA-ICP-MS seems to be the technique of choice, despite the 
problems detected in early works [37]. These problems, however, are better 
understood and can be mitigated nowadays. 
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For instance, the work referred above by Aramendía et al. [66] demonstrated the 
potential of the technique for analysis of DUS. The usage of precut saturated 
DUS as the target sample is very important in this case because the 
inhomogeneity in the distribution of the analytes affects significantly more LA-
ICP-MS, as it is a microsampling technique. Besides this point, use of a suitable 
internal standard (IS) is highly recommended for LA-ICP-MS. This is an important 
aspect and a significant difference with extraction/digestion approaches, where 
addition of an IS is much easier. In this work, it was shown that it is possible to 
deposit the IS standard solution (of Pt) on top of the dried PS-DUS. In this regard, 
the method proposed is thus compatible with simple DUS collection in an 
unsupervised context, and provided LODs of 1 μg L-1 or lower for 9 of the 11 
elements investigated.
Blood is, however, a more complex sample than urine and thus, LA-ICP-MS 
analysis of DBS is a priori more challenging. However, the use of femtosecond 
LA devices operating at a high repetition rate opens some possibilities. With such 
LA devices, it may be feasible to ablate the blood spot completely, thus 
circumventing homogeneity issues and differences in spreading between real 
samples and reconstituted references materials, which can be appreciated even 
by visual inspection, as shown in Figure 5a [38]. 
Instead of the more conventional approach of using delivering high energy pulses 
(> 1 mJ) at low repetition rates (in the range of 1-50 Hz) and using relatively large 
laser spots (e.g., 80-100 μm), these devices deliver relatively low energy laser 
pulses (e.g., < 200 μJ) for small laser spots (10-15 μm) but at very high repetition 
rates (up to 100 KHz) [67]. The laser beam can be moved very fast and with high 
precision, such that overlapping these small spots (see Figure 5a) it is actually 
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possible to efficiently ablate a large area of any shape desired in a reasonable 
time (200 s for a 5 μL DBS). It can be seen in Figures 5b and 5c that the 
distributions of Pb in the DBS of a real blood sample and of a reconstituted 
reference material are very different, but the integrated signals of the complete 
spots are comparable. This way, accurate results (and LODs below 1 μg L-1) 
could be obtained for Cd, Co, Cu and Pb, for real blood samples as well as 
reference materials, relying upon the use of matrix-matched standards for 
calibration. In this case, since addition of an IS solution over the DBS is not 
straightforward (unless some dedicated approach is developed, such as the use 
of a piezo electric spray system [68]), the FP material was impregnated with the 
IS solution and dried, before the deposition of blood droplets [38].
The last paper published on this topic further demonstrates the power of LA-ICP-
MS for multi-element determinations, as long as matrix-matched standards and 
a suitable internal standard are used [69]. 
A technique that has not been used in this context until very recently but provides 
some interesting features is X-ray fluorescence spectrometry (XRF). A novel 
paper evaluates the use of energy dispersive (ED)-XRF for DBS analysis [70]. 
While this technique is not sensitive enough for trace elemental analysis, and still 
requires matrix-matched solid standards for calibration, it is completely non-
destructive, does offer information about the surface of the whole spot, 
minimizing distribution issues, and can provide complementary information for 
elements present at high levels that are also of clinical interest. In this regard, the 
importance of the determination of K can be highlighted, because it has been 
shown that its content can be used to correct for hematocrit variations [58,71,72]. 
Fast, simple and non-destructive analysis of DBS using ED-XRF can therefore 
24
provide valuable information per se (e.g., helping in detect Fe deficiency anemia, 
the most common type of anemia), but also useful information prior to the use of 
other more sensitive but destructive techniques such as LA-ICP-MS (e.g., 
knowing the Fe level enables its signal to be used as IS; knowing the K content 
facilitates correcting for hematocrit variations). 
Overall, despite the difficulties, it is clear that modern atomic spectrometry 
techniques offer enough potential to enable analysis of DMS at practically all 
analyte levels. 
6. Obtaining further information for diagnosis: DMS for isotopic analysis 
A more recent trend is the use of not only elemental, but also of isotopic 
information that can provide key clinical data. This trend has been related with 
the improvements experienced by multicollector (MC)-ICP-MS instruments, 
which can provide the excellent precision (down to 0.002% in the best 
circumstances) needed to detect the small isotopic variations expected, while 
offering much higher sample throughput than other traditional techniques, such 
as thermal ionization mass spectrometry (TIMS), and, also, the potential to 
produce positively charged ions from most elements in the periodic table (TIMS 
typically needs elements to show an ionization energy ≤7.5 eV). These aspects 
have opened possibilities to investigate new isotopic systems, including those of 
essential elements that can be relevant for biomedical applications, such as Ca, 
Cu, Fe or Zn [73]. 
It is beyond the scope of the current review to discuss this topic in detail. The 
readers are instead referred to a recent review by Costas-Rodriguez et al. [73]. It 
is however important, in order to understand the applications reported using 
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DMS, to point out that during biological processes taking place in the human body 
systematic isotope fractionation for the elements mentioned above can occur, 
and that fractionation can be measured with the methodologies available 
nowadays. Such fractionation may be related with some medical conditions and, 
thus, isotopic analysis may help in understanding better how these proceed, and 
even enable to diagnose them more reliably [74,75]. 
One paradigmatic case is Cu and Wilson´s disease (WD). WD it is a genetically 
determined disorder related with Cu metabolism. This clinical condition is caused 
by mutations in the ATP7B gene, which encodes the ATP7B protein. This protein 
facilitates the release of Cu ions from the liver into the bloodstream, by linking 
them to ceruloplasmin, but such function is impaired in WD patients. Thus, Cu 
accumulates in the liver tissue, among other organs, leading to grave health 
issues. 
As a consequence of this mechanism, WD patients show Cu levels in both blood 
and serum that are lower than normal. Therefore, Cu determination in these fluids 
should permit the diagnosis of this disease. This is, however, not that simple 
because young infants, due to the immaturity of their liver, tend to show also Cu 
values that follow the same trend, even when healthy. This fact makes it difficult 
to diagnose this disease properly at early stages, before irreversible damage has 
occurred, which is unfortunate because WD is highly tractable.
In this context, the use of isotopic analysis can be helpful. Since, as discussed 
before, isotope fractionation typically accompanies (bio) chemical reactions, it 
could be expected that the protein ATP7B would interact with the two natural 
occurring isotopes of Cu (63Cu and 65Cu) with slightly different yields. This, in 
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practice, may be very hard to detect in the case of well-functioning proteins 
operating with a high efficiency, close to 100%. However, defective ATP7B 
proteins found in WD patients will show a much lower efficiency for interacting 
with Cu and incorporating it into ceruloplasmin. Therefore, isotope fractionation 
may become more apparent for these persons, thus enabling to differentiate WD 
patients from people that show low Cu blood levels for other reasons. 
MC-ICP-MS analysis of serum proved that such seems to be the case [76]. The 
results for infants showed a Cu level lower than controls, but a similar 65Cu/63Cu 
value. However, patients of WD (and, to some extent, of bariatric surgery) 
showed not only a low Cu level in serum, but a 65Cu/63Cu value that is significantly 
biased low, indicating an enrichment in the lighter isotope, 63Cu. Thus, there is 
potential to diagnose WD even in children, combining elemental and isotopic Cu 
determination. 
The work referred above did not make use of DMS, but of digested serum 
samples, and obtained high precision (0.01%) after Cu isolation. However, if the 
goal is to be able to detect the disease in newborns, the analytical methodology 
should target the biological samples typically used in the screening programs for 
metabolic diseases already implemented throughout the world. In other words, 
DMS analysis would be greatly beneficial. 
Such type of analysis is more challenging, particularly if direct solid sampling is 
aimed at, as the presence of the matrix may affect the results (e.g., 40Ar23Na+ 
overlap with 63Cu+). However, some promising results have been reported. 
Resano et al. used the same fs-LA device discussed in section 5.3. [38] coupled 
to a MC-ICP-MS for Cu isotopic analysis of DUS, as a completely non-invasive 
sampling approach [77]. By ultrafast overlapping of small spots, this LA device 
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can ablate in practice any portion of the DUS, with any geometrical shape. In this 
work, it was decided to ablate small coronas in the rim of the filter, where Cu 
signal intensity was higher, because sensitivity is key to achieve sufficient 
precision with MC-ICP-MS using Faraday cups as detectors [77]. 
In the end, a method was proposed based on a) deposition of 300 μL of urine 
onto precut (16 mm diameter) FP; b) air drying for 4h; and, c) Cu isotopic analysis 
of the DUS using fs-LA-ICP-MS with the LA operating a 10,000 Hz and ablating 
the abovementioned coronas, the MC-ICP-MS operating in pseudo high-
resolution mode to avoid spectral overlap, simultaneously admixing a Ni solution 
as internal standard to correct for mass bias, and finally processing the transient 
signals using a linear regression approach to enhance precision. 
While precision values were not as good as those obtained after sample digestion 
and analyte isolation (0.05% RSD for urinary Cu contents of a few hundred μg L-
1), it was possible to appreciate that untreated WD patients show a 65Cu/63Cu 
biased low, while WD patients under treatment with a chelating agent show a 
ratio comparable to that of a control sample (very close to natural abundance). 
These results further prove the potential interest of the approach for diagnosis, 
as well as the success of the treatment, although a larger number of samples 
should be analyzed to confirm them [77]. 
Authors from the same research groups also analyzed DBS samples, in this case 
using the same LA device simultaneously coupled to two ICP-MS instruments: 
one high-resolution sector field-ICP-MS that provides excellent sensitivity and 
resolution for elemental analysis and one MC-ICP-MS that provides more 
precision for isotopic analysis [38]. Therefore, simultaneous elemental (Cd, Cu, 
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Co, Pb) and isotopic analysis (Cu) could be carried out, thus maximizing the 
amount of information that can be drawn from a single DBS specimen. The results 
for quantitative elemental analysis were discussed in the previous section. 
Regarding Cu isotopic determination, the precision of the approach was found to 
be limited at this point, with RSD values of approximately 0.15 %. 
The last article to be published on this topic investigated the use of VAMS (see 
section 3 for details) for isotopic analysis of Fe. This topic is relevant because it 
may provide information to achieve a better understanding of human Fe 
metabolism, as well for the diagnosis of Fe related disorders, such as 
hemochromatosis and anemia of chronic disease, among others. 
After finger-prick sampling, it was feasible to extract Fe quantitatively from the 
VAMS into 1 mL of milli-Q water, which was followed by acid digestion and 
chromatographic isolation to provide the high-precision needed for monitoring Fe 
ratios in biomedical applications. No significant difference was observed between 
paired finger-prick and venous blood samples, regarding both Fe concentrations 
and isotope ratios [78]. 
While the number of groups working in this field, with access to MC-ICP-MS 
instrumentation and to personnel with a biomedical background and samples, is 
still limited, its relevance permits anticipating a growing interest and further 
results in upcoming years. 
7. Outlook and conclusions 
Despite the current importance of DMS, and of DBS in particular, as a biological 
specimen, this type of sample is still underutilized when aiming at obtaining 
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elemental information. It is, however, our view that this situation is changing, and 
that the arrival of new sampling devices and methodological approaches based 
on a constant volume make it easier to obtain reliable information on elemental 
contents.
In particular, the development of simple approaches that can be automated 
relying either on simple analyte extraction procedures or on solid sampling 
methodologies, are prospective areas of research. Still, the problem of 
contamination remains to be solved as the number of analytes to be monitored 
expands. 
Finally, this methodology could benefit from the new type of information that can 
be obtained based on isotopic analysis of non-traditional stable isotopes, such as 
those of Cu, Fe or Zn, which can contribute to diagnose and better understand 
some diseases. 
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Figure Captions
Figure 1. a) Publications on DBS; b) Publications on DUS. Conference papers 
were excluded. Source: Scopus, October 31, 2017. 
Figure 2. Biosampling using DBS. Simplified analytical procedure for DBS 
analysis. 
Figure 3. a) Sampling blood at home using a VAMS device (left), and comparison 
of a VAMS device before and after sampling (right); b) Microfluidic-based device 
(patent WO/2013/144743 A1) for sampling blood. The sampling procedure 
consists of the following steps: (a) sliding the selected FP card into the cover slot; 
(b) filling the channels by contacting the fingertip blood drop with the inlet; (c) 
transferring the fixed blood volume onto the FP card by closing the cover; and (d) 
opening the cover and removing the FP card containing the DBS samples, which 
can then be processed as shown in Figure 2 (reprinted with permission from [28], 
copyright 2015 American Chemical Society). 
Figure 4. a) Visual comparison of the sample concentration per area unit 
achieved when using DUS (above) and precut saturated-DUS specimens 
(below), respectively. DUS specimens were obtained by directly blotting the 
corresponding volumes of urine onto a Whatman 903 FP card with a micropipette, 
while precut saturated-DUS specimens were obtained by blotting 300 μL of urine 
onto precut FP discs (16 mm diameter), placed over a hydrophobic surface (a 
polycarbonate disc). Adapted with permission from [66]. Copyright 2012 
American Chemical Society. b) Different steps for the direct Mo and Ti 
determination in DUS by HR CS GF-AAS. Adapted from ref. [51], copyright 2013, 
with permission from Elsevier. 
36
Figure 5. a) Schematic representation of the ablation protocol used for complete 
ablation and analysis of 5 mL DBS. 5–6 mm diameter craters (depending on the 
DBS size) were constructed by ablating 250–285 concentric circumferences from 
the inside to the outside of the DBS. Approximated radial distribution of Pb in 5 
mL DBS obtained from: b) a real sample; c) Seronorm level II reference sample. 
Each bar represents the integrated 208Pb+ signal, normalized for a concentration 
of 1 μg L-1, for the ablated corona with internal and external radius indicated in 
the x-axis in the figure. Adapted from ref. [38] with permission from the Royal 
Society of Chemistry
(http://pubs.rsc.org/en/content/articlelanding/2015/ja/c4ja00313f#!divAbstract).
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Table 1. Elemental determinations carried out in DMS samples.
Analyte Sample Method Remarks Year Ref.
Pb blood F-AAS Analysis of blood microsamples (10 μL) 
with the Delves Cup
1970 [31]
Pb DBS F-AAS Direct analysis of DBS with the Delves 
Cup
1971 [32]
Pb DBS F-AAS Further direct analysis of DBS with the 
Delves Cup. Method comparison
1973 [79]
Pb DBS F-AAS Further direct analysis of DBS with the 
Delves Cup. Method comparison
1974 [34]
Pb DBS F-AAS Delves Cup. Effect of abnormal 
haemoglobin values.
1978 [36]
Pb DBS F-AAS Modification of the Delves method by 
previous calcination of the sample.
1991 [33]
Pb DBS GF-AAS Extraction with (NH4)2HPO4 and Triton 
X-100 solutions. Matrix-matched 
standards for calibration
1992 [80]
Pb DBS F-AAS Direct analysis of DBS with the Delves 
Cup. Method comparison 
1994 [81]
Pb DBS F-AAS Direct analysis of DBS with the Delves 
Cup. Method comparison 
1995 [82]
Pb DBS GF-AAS Extraction with HNO3 and Triton X-100 
solutions
1995 [83]
Pb DBS ICP-MS Extraction with a HNO3 solution. Y 
added to the solution as IS.
1995 [84]
Pb DBS GF-AAS Similar to [83] 1997 [85]
Pb DBS GF-AAS Similar to [83] 1998 [86]
Pb DBS GF-AAS, 
F-AAS
Interlaboratory comparison 1999 [87]
Pb DBS GF-AAS Extraction with a HNO3 solution 2003 [88]
Pb DBS GF-AAS EDTA plus (NH4)2HPO4, HNO3 and 
Triton X-100 to extract Pb
2004 [41]
Pb DBS ICP-MS Influence of sampling different areas of 
the DBS
2007 [39]
Pb DBS LA-ICP-
MS
Direct analysis. Feasibility study 2007 [37]
Pb DBS GF-AAS Direct analysis. Calibration with matrix-
matched standards
2007 [40]
Cd, Hg, 
Pb
DBS ICP-MS Extraction with HCl, 2-mercaptoethanol 
and L-cysteine solutions
2009 [42]
Pb DBS ICP-MS Investigation of blood volumes and spot 
geometry
2009 [35]
28 
elements
DBS ICP-MS Extraction with HNO3 and Triton X-100 
solutions
2011 [44]
As, Cd, 
Pb, Hg, 
Se plus 
organic 
pollutants
DBS ICP-MS Database for exposure to environmental 
toxicants via analysis of avian blood 
spots 
2011 [49]
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Pb DBS ICP-MS Method similar to [39]. Relationship 
between prenatal and infant blood lead 
levels 
2012 [89]
As, Cd, 
Pb, Hg, 
Se plus 
organic 
pollutants
DBS ICP-MS Examination of Eurasian griffon vultures 
via DBS
 
2012 [50]
Be, Bi, 
Cd, Co, 
Cu, Ni, 
Sb, Sn, 
Tl, Pb, V
DUS LA-ICP-
MS
Direct analysis. Deposition on precut-
saturated DUS. Pt as IS. Calibration with 
matrix-matched standards
2012 [66]
As, Cd, 
Hg, Pb
DBS ICP-MS Improved procedure from [44]. Addition 
of Au in the extraction solution to 
amalgamate Hg and enhance recovery
2013 [46]
Ti and Mo DUS HR CS 
GF-AAS
Direct analysis. Urine deposition on 
precut-saturated DUS. Calibration with 
matrix-matched standards.
2013 [51]
As, Cd, 
Hg, Pb, 
Se, Tl
DBS ICP-MS Overnight digestion with concentrated 
nitric acid at 95 ºC. 
2013 [90]
I DUS MAS Photometric approach after Sandell–
Kolthoff reaction 
2013 [60]
K DBS Potentio-
metry
Prediction of the hematocrit of DBS via 
potassium measurement 
2013 [71]
As, Cd, 
Cu, Pb, 
Mo, Se, 
Zn
DBS ICP-MS Acid digestion and matrix-matched 
calibration with reference materials
2014 [91]
K DBS Potentio-
metry
Correction of the hematocrit effect in 
DBS via potassium measurement 
2015 [72]
As, Cd, 
Hg, Pb
DBS ICP-MS Similar procedure to [46] 2015 [59]
Pb DBS GF-AAS Similar procedure to [41] 2015 [92]
Pb DBS HR CS 
GF-AAS
Direct analysis. Performance as a 
quantitative or as screening method
2015 [64]
Cd, Cu, 
Co, Pb 
DBS LA-ICP-
MS
Direct analysis by complete ablation of 5 
μL DBS. Calibration with matrix-matched 
standards. Pt as IS.
2015 [38]
I DUS MAS Photometric approach after Sandell–
Kolthoff reaction 
2015 [61]
Al, Ti, V, 
Co, Cr, 
Ni, Sr, Zr 
DBS ICP-MS Use of VAMS and extraction in water. 
ICP-MS/MS analysis for coping with 
spectral overlap.
2016 [56]
I DUS MAS Photometric approach after Sandell–
Kolthoff reaction 
2016 [62]
Hg DBS ICP-MS Underestimated values for Hg in DBS 
compared with cord blood. Likely due to 
poor extraction efficiency.
2016 [47]
11 
elements
DBS ICP-MS Use of VAMS and extraction in water. 
Use of hTISIS for microsampling.
2017 [57]
44
15 
elements
DBS ICP-MS Simultaneous measurement of K and Fe 
in DBS extracts may be used to 
estimate sample hematocrit. 
2017 [58]
19 
elements
DBS LA-ICP-
MS
Matrix-matched standards for 
calibration. 13C and 32S were used for 
signal intensity normalization
2017 [69]
Pb DBS ICP-MS Extraction in a solution containing 
tetramethylammonium hydroxide, 
isopropyl alcohol, and ammonium 
pyrrolidine dithiocarbamate 
2017 [43]
Cl, Fe, K, 
P, S
DBS ED-XRF Direct non-destructive analysis; 
matrix-matched standards for calibration
2017 [70]
I DUS MAS Photometric approach after Sandell–
Kolthoff reaction
2017 [63]
MeHg DBS GC-CV-
AFS
Separation of Hg species and 
quantification of MeHg
2017 [48]
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Table 2. Titanium isotopes with their natural isotopic abundance and the most 
important isobaric and polyatomic interferences (non-restrictive list). Reproduced 
from [55], copyright 2014, with permission from Elsevier.
Analyte Abundance 
(%)
Isobaric 
interferences
Polyatomic Interferences
46Ti+ 8.25 Ca+ (0.004a) 32S14N+, 14N16O2+, 15N216O+
47Ti+ 7.44 ---
32S14N1H+, 30Si16O1H+, 32S15N+, 33S14N+, 
15N16O2+, 14N16O21H+, 12C35Cl+, 31P16O+
48Ti+ 73.72 Ca+ (0.187a)
32S16O+, 34S14N+, 33S15N+, 14N16O18O+, 
14N17O2+, 12C4+, 36Ar12C+
49Ti+ 5.41 ---
32S17O+, 32S16O1H+, 35Cl14N+, 34S15N+, 
33S16O+, 14N17O21H+, 14N35Cl+, 36Ar13C+, 
36Ar12C1H+, 12C37Cl+, 31P18O+, 31P17O1H+
50Ti+ 5.18 Cr
+ (4.345a), V+ 
(0.25a)
32S18O+, 32S17O1H+, 36Ar14N+, 35Cl15N+, 
36S14N+, 33S17O+, 34S16O+, 35Cl14N1H+, 
34S15N1H+
a Isotopic abundance (%) for isobaric interferences
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Table 3. Diagnostic efficiency values for the screening method proposed in [64] 
for a critical value (threshold) of 50 μg L-1 Pb. Adapted from [64] with permission 
of Newlands Press Ltd.
Prevalence
(%)
Cut-off
(μg L−1)
Sensitivity
(%)
Specificity 
(%)
FNR 
(%)
FPR 
(%)
NPV 
(%)
PPV 
(%)
All samples
 (n = 526) 21.7 38 96.6 87.8 3.4 12.2 98.9 83.3
Newborns
 (n = 229) 1.3 38 100 85.8 0 14.2 100 8.6
Pregnant 
women
 (n = 185)
1.1 38 100 90.2 0 9.8 100 10.0
Prevalence: percentage of true positives in the population investigated; Sensitivity: % of 
positives correctly identified as such; Specificity: % of negatives correctly identified as such; 
FNR: False Negative Rate; FPR: False Positive Rate; NPV: Negative Predictive Value; PPV: 
Positive Predictive Value.
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Table 4. Isotopic determinations carried out in DMS samples.
Analyte Sample Method Remark Year Ref.
Cu DUS LA-MC-ICP-MS Direct analysis. Urine deposition 
on precut-saturated DUS. Ni 
solution as IS
2013 [77]
Cu DBS LA coupled with 
both SF-ICP-MS 
and MC-ICP-MS
Simultaneous elemental (Cd, 
Co, Cu, Pb) and isotopic 
analysis (Cu). Ni solution as IS
2015 [38]
Fe DBS MC-ICP-MS Use of VAMS and extraction in 
water, followed by acid digestion 
and Fe isolation by 
chromatographic separation
2017 [78]
